Jaideep Vaidya, a distinguished professor at Rutgers Business School, was recently inducted by the American Institute for Medical and Biological Engineering (AIMBE) to its College of Fellows. The ...

FIU professors Angela Laird and Jorge Riera Diaz were recently inducted into the 2024 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Election to the ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, catalysis, medicine, complex systems, ...

Karin Wuertz-Kozak, a faculty researcher at Rochester Institute of Technology, was recently inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

The Department of Chemical and Biological Engineering is updating one of its undergraduate majors to offer students greater flexibility in exploring biological engineering-focused courses. Starting in ...

Jun Zhuang, associate dean for research in the School of Engineering and Applied Sciences, and Morton C. Frank professor in the Department of Industrial and Systems Engineering, has been elected a ...

Biological engineering and chemical engineering are dynamic, innovative fields at the forefront of biotechnology, therapeutics, renewable and sustainable energy, nanotechnology, carbon reduction and ...

Case Western Reserve University professor Shuo Li, PhD, has been elected a fellow of the International Academy of Medical and Biological Engineering (IAMBE), one of the highest international honors in ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, medicine, complex systems, energy, ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the Councils of the National Academy of ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...